Scroll to READ
Seeing Her Son Struggle with ADHD Finally Caused Her to Get Help
Subheading style here
For as long as she can remember, Michele had problems focusing, often leaving parts of her life unfinished. She struggled with this in school throughout her entire childhood and into her college years. As an adult, she had trouble focusing on certain tasks for her job and her procrastination persisted when Michele became a mother and homemaker.
“It would be August and the Christmas decorations would still be up,” Michele recalled. “I’d have so many projects laying around the house because I could never quite get them done.”
Did you know?
frequently diagnosed cancer in women, and endometrial cancer (which accounts for 90% of uterine cancers) is one of the few cancers where both diagnoses and death rates are increasing in the U.S.
Uterine cancer is the fourth most
Qelbree is the first 2-bead Microtrol Technology delivery of nonstimulant viloxazine for 24-hour patient exposure.
Qelbree shows no evidence of abuse potential –minimizing risk of treatment abuse, misuse or diversion.
Adolescents 12 to 17
years of age
In the study of adolescents 12 to 17 years of age, ADHD symptom score reductions were statistically significant for the 400mg dose, beginning at week 2.
Adults 18 to 65
years of age
In the flexible-dose study of adults 18 to 65 years of age, ADHD symptom score reductions were statistically significant in the Qelbree patients, beginning at week 2.
For Michele, her ADHD diagnosis came with a flood of emotions.
“I was relieved, sad, and excited—all at the same time,” she said.
The sadness came because Michele had struggled without an understanding of her condition for so many decades.
“If I had to use one word to describe what ADHD feels like, I’d say cloud,” said Michele. With her diagnosis came relief, Michele finally understood why she had been feeling like this.
Children and adults living with undiagnosed ADHD often face intense frustration at seemingly not being able to perform the tasks they know they want to perform.
Know your body
Be an advocate for yourself and other women
How it works
It took Michele’s 10 year old son to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) for her to notice she was exhibiting similar traits—inability to focus, impulsivity, hyperactivity. When her son was diagnosed, his psychiatrist happened to mention that the condition is genetic.
“He asked me if I thought I had ADHD and I told him I know I have ADHD,” Michele said.
“ADHD is now recognized as one of the most common psychiatric diagnoses and it’s not only diagnosed in children,” said Dr. Ann Childress, MD President of the Center for Psychiatry and Behavioral Medicine in Las Vegas, NV. “Nearly five percent of adults in the U.S. are living with ADHD while nearly one out of every 10 American children and teens have been diagnosed with ADHD.”
Recognizing and voicing below the belt symptoms may help end the stigma around endometrial cancer.
Visit Qelbree.com for More Information
Visit SpotHerforEC.com for Resources
Sponsored by Supernus Pharmaceuticals
Sponsored by Supernus Pharmaceuticals
“Children and adults living with undiagnosed ADHD often face intense frustration at seemingly not being able to perform the tasks they know they want to perform,” explained Dr. Childress.
With knowledge comes empowerment. After being diagnosed, Michele said she was excited about the possibility of treatment.
“ADHD treatment should be tailored to each person’s needs and circumstances,” said Dr. Childress. “Initial treatment is often focused on behavioral management techniques and support, but when that’s not enough, medication may play an important role in treating core symptoms of ADHD.”
Michele’s son had been prescribed Qelbree (viloxazine extended-release capsules), the most commonly prescribed branded nonstimulant ADHD medication*, and had seen positive results in his day-to-day ADHD symptom control. As a once-a-day nonstimulant prescription medicine used to treat ADHD in adults and children ages 6 years and older, Qelbree is the first novel, nonstimulant approach in ADHD in over a decade and the first nonstimulant approved for adults with ADHD in 20 years.
Environmental Social Governance (ESG) Milestones
Currently 46% diverse executive management team.
Contributed >$9.5 million to charitable organizations.
Decreased Total Recordable Injuries by 21%.
Scored a Scored a 90 out of 100 on Human Rights Commitment.
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.
Important Safety Information continued below.
IMPORTANT SAFETY INFORMATION
“Patients who choose not to take stimulant medications or who have experienced tolerability issues with stimulant medications are good candidates for a trial of Qelbree,” said Dr. Childress.
“With Qelbree, I knew there was hope,” Michele said, pointing to her son’s success with Qelbree and how similar her symptoms were to her son as a child. Ninety percent of children diagnosed with ADHD continue to have ADHD symptoms into adulthood. “When I started Qelbree, the cloud of ADHD lifted. I could have a single thought—not like 20 at the same time—and things were clear. The sun came out!”
Michele noted that as a mom of three, she has benefited in several ways from taking Qelbree for the last year. Qelbree has helped her stay organized, and she feels more self-aware, more focused on her family’s needs, and more motivated to do tasks that will help encourage her children’s success.
And compared to Michele’s previous ADHD medication—which was a stimulant—nonstimulant Qelbree is more easily accessible at the pharmacy. Qelbree has demonstrated no evidence of abuse potential and is available for 90-day refills without additional doctor appointments.
“I can go to the pharmacy and get my prescription three months at a time,” said Michele. “It’s also easy for me to take. Qelbree is a once a day medication and I can take it at any time.”
1.
2.
3.
4.
Qelbree [package insert]. Rockville, MD: Supernus Pharmaceuticals, Inc.
Data on file, Supernus Pharmaceuticals.
Yanagita T, Wakasa Y, Kiyohara H. Drug dependence potential of viloxazine hydrochloridetested in rhesus monkeys. Pharmacol Biochem Behav. 1980;12:155-161.
Sibley MH, Arnold LE, Swanson JM, et al. Variable Patterns of Remission from ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry 2022; 179(2):142-151. doi:10.1176/appi.ajp.2021.21010032.
Please revisit on a desktop device!
This experience is not yet optimized for your mobile screen.
When I started Qelbree, the cloud of ADHD lifted. I could have a single thought—not like 20 at the same time—and things were clear. The sun came out!
Qelbree has given hope to many people just like Michele. As a potentially appropriate treatment option for millions of U.S. children aged 6 years and older, adolescents, and adults who have ADHD, Qelbree has the potential to make a profound impact on the ADHD community.
"Difficulty with medication tolerability, coupled with the national shortage of many stimulants, highlights the need for alternatives such as Qelbree,” said Dr. Childress. "Given Qelbree is a non-controlled substance and has no evidence of abuse or misuse, it makes an excellent alternative that can be easily incorporated into your ADHD treatment regimen."
If you’ve struggled with ADHD or suspect to be one of the millions of people undiagnosed with ADHD, talk to your doctor about Qelbree to see if it might be right for you.
Please see here for full Prescribing Information, including Boxed Warning. You can learn more about Qelbree at Qelbree.com.
IMPORTANT SAFETY INFORMATION (CONTINUED)
Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.
Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.
The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
®
®
*As of August 2023
4
Qelbree was found to be free of physical drug dependence in 5 animal models of abuse liability.
No withdrawal symptoms or signs of dependence were reported as adverse events (AE) during human clinical trials.
Qelbree is the only nonstimulant ADHD treatment that can be sprinkled, making it easier to take for patients who are unable to swallow capsules.
IMPORTANT SAFETY INFORMATION
You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.
Important Safety Information continued below.
Concomitant administration of sensitive CYP1A2 substrates or CYP1A2 substrates with a narrow therapeutic range
1,2
2,3
3
2
®
Not only is Qelbree accessible at the pharmacy, it’s also the only nonstimulant ADHD treatment that can be sprinkled making it easier to take for patients who are unable to swallow capsules. Additionally, Michele and her family appreciate the affordability the Qelbree prescription savings card provides; it helps them save money monthly. The true benefit of Qelbree has been helping to make Michele’s and her son’s ADHD symptoms more manageable each day.
“Our life at home has changed dramatically since we started Qelbree,” Michele said. “My son is able to do his homework on his own and I can focus on the things I need. Together, as a team, we can get things done.”
“Qelbree has changed my life and my son’s life. It’s given us an incredible tool that can help.”
IMPORTANT SAFETY INFORMATION
Qelbree can increase blood pressure and heart rate.
Your or your child's doctor will monitor these vital signs.
Important Safety Information continued below.
Real Patients
Real Patients
Real Patients
QBE.2023-0307
For Michele, her ADHD diagnosis came with a flood of emotions.
“I was relieved, sad, and excited—all at the same time,” she said.
The sadness came because Michele had struggled without an understanding of her condition for so many decades.
“If I had to use one word to describe what ADHD feels like, I’d say cloud,” said Michele. With her diagnosis came relief, Michele finally understood why she had been feeling like this.
Children and adults living with undiagnosed ADHD often face intense frustration at seemingly not being able to perform the tasks they know they want to perform.
“Children and adults living with undiagnosed ADHD often face intense frustration at seemingly not being able to perform the tasks they know they want to perform,” explained Dr. Childress.
With knowledge comes empowerment. After being diagnosed, Michele said she was excited about the possibility of treatment.
“ADHD treatment should be tailored to each person’s needs and circumstances,” said Dr. Childress. “Initial treatment is often focused on behavioral management techniques and support, but when that’s not enough, medication may play an important role in treating core symptoms of ADHD.”
Michele’s son had been prescribed Qelbree (viloxazine extended-release capsules), the most commonly prescribed branded nonstimulant ADHD medication*, and had seen positive results in his day-to-day ADHD symptom control. As a once-a-day nonstimulant prescription medicine used to treat ADHD in adults and children ages 6 years and older, Qelbree is the first novel, nonstimulant approach in ADHD in over a decade and the first nonstimulant approved for adults with ADHD in 20 years.
Qelbree is the first 2-bead Microtrol Technology delivery of nonstimulant viloxazine for 24-hour patient exposure.
Qelbree shows no evidence of abuse potential –minimizing risk of treatment abuse, misuse or diversion.
How it works
“Patients who choose not to take stimulant medications or who have experienced tolerability issues with stimulant medications are good candidates for a trial of Qelbree,” said Dr. Childress.
“With Qelbree, I knew there was hope,” Michele said, pointing to her son’s success with Qelbree and how similar her symptoms were to her son as a child. Ninety percent of children diagnosed with ADHD continue to have ADHD symptoms into adulthood. “When I started Qelbree, the cloud of ADHD lifted. I could have a single thought—not like 20 at the same time—and things were clear. The sun came out!”
Michele noted that as a mom of three, she has benefited in several ways from taking Qelbree for the last year. Qelbree has helped her stay organized, and she feels more self-aware, more focused on her family’s needs, and more motivated to do tasks that will help encourage her children’s success.
And compared to Michele’s previous ADHD medication—which was a stimulant—nonstimulant Qelbree is more easily accessible at the pharmacy. Qelbree has demonstrated no evidence of abuse potential and is available for 90-day refills without additional doctor appointments.
“I can go to the pharmacy and get my prescription three months at a time,” said Michele. “It’s also easy for me to take. Qelbree is a once a day medication and I can take it at any time.”
Not only is Qelbree accessible at the pharmacy, it’s also the only nonstimulant ADHD treatment that can be sprinkled making it easier to take for patients who are unable to swallow capsules. Additionally, Michele and her family appreciate the affordability the Qelbree prescription savings card provides; it helps them save money monthly. The true benefit of Qelbree has been helping to make Michele’s and her son’s ADHD symptoms more manageable each day.
“Our life at home has changed dramatically since we started Qelbree,” Michele said. “My son is able to do his homework on his own and I can focus on the things I need. Together, as a team, we can get things done.”
“Qelbree has changed my life and my son’s life. It’s given us an incredible tool that can help.”
IMPORTANT SAFETY INFORMATION
Qelbree can increase blood pressure and heart rate.
Your or your child's doctor will monitor these vital signs.
Important Safety Information continued below.
Qelbree has given hope to many people just like Michele. As a potentially appropriate treatment option for millions of U.S. children aged 6 years and older, adolescents, and adults who have ADHD, Qelbree has the potential to make a profound impact on the ADHD community.
"Difficulty with medication tolerability, coupled with the national shortage of many stimulants, highlights the need for alternatives such as Qelbree,” said Dr. Childress. "Given Qelbree is a non-controlled substance and has no evidence of abuse or misuse, it makes an excellent alternative that can be easily incorporated into your ADHD treatment regimen."
If you’ve struggled with ADHD or suspect to be one of the millions of people undiagnosed with ADHD, talk to your doctor about Qelbree to see if it might be right for you.
Please see here for full Prescribing Information, including Boxed Warning. You can learn more about Qelbree at Qelbree.com.
IMPORTANT SAFETY INFORMATION (CONTINUED)
Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.
Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.
The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effe[CEROS OBJECT]cts of Qelbree.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
®
Sponsored by Supernus Pharmaceuticals
1.
2.
3.
4.
Real Patients